Pharming PHAR
NASDAQ PHAR
$9.75 -0.20 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Change in Acquisitions & Divestments (2023 - 2026)

Updated

Pharming (PHAR) reported Change in Acquisitions & Divestments of -$102.65 million for Q2 2026.

Analysis

Pharming (PHAR) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Pharming's Change in Acquisitions & Divestments came in at -$496.76 million; for FY2025, it was -$2,000.

  • By year, Change in Acquisitions & Divestments came in at -$284.31 million in FY2024 and -$382.01 million in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly Change in Acquisitions & Divestments since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pharming 684.14 Mn -146.02 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -102.65 Mn
Dec 31, 2025 -2,000.00
Dec 31, 2024 -284.31 Mn
Sep 30, 2024 -109.80 Mn
Jun 30, 2024 -112.45 Mn
Dec 31, 2023 -382.01 Mn
Sep 30, 2023 -144.55 Mn
Jun 30, 2023 -87.35 Mn
API Access

Pharming Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=PHAR&period=max&api_key=YOUR_API_KEY